These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 104546)

  • 1. Pilot study on the growth inhibition by estramustine phosphate (Estracyt) of rat mammary tumours sensitive and insensitive of oestrogen.
    Müntzing J; Jensen G; Högberg B
    Acta Pharmacol Toxicol (Copenh); 1979 Jan; 44(1):1-6. PubMed ID: 104546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of estramustine phosphate (Estracyt) on transplantable mouse tumours.
    Wakisaka M; Iwasaki I; Shimazaki J
    Urol Res; 1979 Dec; 7(4):291-8. PubMed ID: 524566
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of oestrogen-escaped carcinoma of the prostate with estramustine phosphate.
    Chisholm GD; O'Donoghue EP; Kennedy CL
    Br J Urol; 1977; 49(7):717-20. PubMed ID: 339986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of prostatic cancer with Estracyt (estramustine phosphate).
    Balogh F; Kisbenedek L
    Int Urol Nephrol; 1975; 7(2):135-40. PubMed ID: 1102475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The absorption metabolism, and excretion of Estracyt (NSC 89199) in patients with prostatic cancer.
    Forshell GP; Müntzing J; Ek A; Lindstedt E; Dencker H
    Invest Urol; 1976 Sep; 14(2):128-31. PubMed ID: 972005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
    Wong AL; McGeorge A; Abel BJ
    Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hormone-resistant prostate cancer with estramustine phosphate (Estracyt)].
    Stridsklev IC; Fosså SD; Kaalhus O
    Tidsskr Nor Laegeforen; 1984 Oct; 104(28):1977-80. PubMed ID: 6388019
    [No Abstract]   [Full Text] [Related]  

  • 8. Estramustine phosphate: a specific chemotherapeutic agent?
    Von Hoff DD; Rozencweig M; Slavik M; Muggia FM
    J Urol; 1977 Apr; 117(4):464-6. PubMed ID: 850319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of prior hormonal therapy to subsequent estramustine phosphate treatment in advanced prostatic cancer.
    Slack NH; Wajsman Z; Mittelman A; Bruno S; Murphy GP
    Urology; 1979 Dec; 14(6):549-54. PubMed ID: 390810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S; Kishimoto T; Maekawa M; Kawakita J; Hayahara N; Yuki K; Morikawa Y; Yasumoto R; Kato Y; Funai K
    Hinyokika Kiyo; 1986 Nov; 32(11):1763-70. PubMed ID: 3825823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extended therapy of stage D carcinoma of the prostate with oral estramustine phosphate.
    Mittelman A; Shukla SK; Murphy GP
    J Urol; 1976 Apr; 115(4):409-12. PubMed ID: 1263317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostatic cancer. Transcortin levels during treatment with estramustine phosphate.
    Sandberg AA; Rosenthal H; Mittelman A; Murphy GP
    Urology; 1975 Jul; 6(1):17-21. PubMed ID: 1145919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on phenolic steroids in human subjects. XIV. Fate of a nitrogen mustard of estradiol-17beta.
    Kirdani RY; Mittelman A; Murphy GP; Sandberg AA
    J Clin Endocrinol Metab; 1975 Aug; 41(2):305-18. PubMed ID: 808555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiographic studies of 3H-estramustine in the rat ventral prostate.
    Appelgren LE; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Acta Pharmacol Toxicol (Copenh); 1978 Nov; 43(5):368-74. PubMed ID: 726901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estramustine-binding protein in rat and human prostate.
    Forsgren B
    Scand J Urol Nephrol Suppl; 1988; 107():56-8. PubMed ID: 3287598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oestrogenic effects of ethinyl oestradiol/polyoestradiol phosphate and estramustine phosphate in patients with prostatic carcinoma. A comparative study of oestrogen sensitive liver proteins, gonadotrophins and prolactin.
    Daehlin L; Damber JE; von Schoultz B; Bergman B
    Br J Urol; 1986 Aug; 58(4):412-6. PubMed ID: 3092893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative affinities of estramustine phosphate metabolites to the cytosol oestrogen receptor of rat testis.
    Daehlin L; Södergård R; Damber JE
    Scand J Clin Lab Invest; 1986 Apr; 46(2):159-62. PubMed ID: 3715367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of advanced estrogen-resistant cancer of the prostate with estramustine phosphate. A phase-2 study].
    Trykker HU
    Ugeskr Laeger; 1985 Oct; 147(42):3310-2. PubMed ID: 4082315
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
    Boylan ES; Fowler EH; Wittliff JL
    Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.